Evidence map›Paper›PMID 42514755›Full record

ArticlePolymers2026

Hyaluronic Acid Molecular Weight Modulates Chitosan-Gelatin Scaffold Properties and Cancer Cell Organization in 3D Culture.

Leimapokpam Romina Chanu, Guo-Chung Dong, Ping-Shan Lai

Abstract read
In one paragraph

Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Leimapokpam Romina ChanuDoctoral Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University, Taichung City 402204, Taiwan.
Guo-Chung DongInstitute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Miaoli County 35053, Taiwan.ORCID 0000-0003-1159-1718
Ping-Shan LaiDoctoral Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University, Taichung City 402204, Taiwan.

Funding

National Science and Technology Council 114-2113-M-005-012
6 · The paper itself

Abstract

Reconstructing physiologically relevant in vitro tumor microenvironments (TMEs) that capture coupled biophysical and biochemical complexities remains a significant challenge in cancer modeling. Here, we present a tunable chitosan-gelatin-hyaluronic acid (HA) scaffold platform stabilized by Schiff-base (C=N) crosslinking to investigate how HA molecular weight (MW) affects scaffold architecture, hydration behavior, mechanical properties, degradation stability, and cancer cell organization. We established an isocompositional series of HA-containing scaffolds, with HA MW as the primary variable and polymer composition held constant across all HA-containing groups. Varying HA MW modulated pore morphology, swelling behavior, compressive modulus, and degradation profiles, demonstrating distinct effects on scaffold structural organization. Medium-MW HA yielded a balanced scaffold architecture characterized by high porosity, controlled swelling behavior, and stable mechanical performance under hydrated conditions. A549 cells exhibited a compact, spheroid-like organization, whereas PANC-1 cells displayed more protrusive, spread morphologies that varied with scaffold formulation. Conversely, HA-free scaffolds showed reduced structural stability and less organized three-dimensional (3D) cell morphology. Collectively, these findings substantiate that HA MW is an effective design parameter for tuning scaffold physicochemical properties and influencing scaffold-associated cancer cell organization in 3D culture. This study provides a tunable scaffold platform for future in vitro tumor microenvironment modeling.

Indexed as

3D cancer modelscell–matrix interactionchitosan–gelatin scaffoldhyaluronic acidmatrix biomechanics

Identifiers

PMID42514755
PMCPMC13417349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.